Long-term safety and lasting effects of fat-reducing injection
Treatments studied
Part of Skin clinical trials.
This study checks whether the fat-reducing effects from the earlier treatment last over time, and whether the treatment is safe to use long-term. It is only for people who already took part in the first part of this study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed the first part of this study and had at least one treatment (either the study drug or a placebo).
- You must be willing to keep your diet and exercise routine steady during the study.
- You must be willing to avoid other treatments that could affect the area being studied.
- You must not be taking any weight-loss pills (prescription or over-the-counter) or be in a weight-loss program.
- If you are a woman who could become pregnant, you must use reliable birth control and not be pregnant or breastfeeding. If you are a man, you must consistently use condoms.
- You must be willing to avoid donating eggs or sperm for a certain period after the last treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called CBL-514 that is designed to reduce fat under the skin in the belly area. It might help people who are dissatisfied with stubborn abdominal fat that doesn't go away with diet and exercise.
This study tests a new injectable treatment, CBL-514, to reduce belly fat. It may help people who have stubborn abdominal fat that doesn't go away with diet and exercise.
This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.
This study tests an injection called CBL-514 that may help reduce belly fat. It is for adults with extra abdominal fat who want a non-surgical option.
This trial tests a new injection called MI226 to reduce belly fat. It is for people with noticeable belly fat who want to see if this treatment can help slim that area.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
Hear when a new Subcutaneous Fat trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.